Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Antidiabetic activity of mefloquine via GLP-1 receptor modulation against STZ–NA-induced diabetes in albino wistar rats

Antidiabetic activity of mefloquine via GLP-1 receptor modulation against STZ–NA-induced diabetes... Mefloquine was retrieved as a glucagon -like peptide-1 receptor agonist and, therefore, evaluated for its antidiabetic potential against non-insulin-dependent diabetes mellitus (NIDDM) in experimental animals. NIDDM was induced by single intraperitoneal injection of streptozotocin and nicotinamide (60 + 110 mg/kg) in albino wistar rats. The experimental animals were scrutinised for electrocardiographic (ECG) and heart rate variability (HRV) factors to study the autonomic dysfunction along with blood glucose, serum insulin, and liver glycogen levels for glycemic control. Simultaneously, antioxidant markers (TBARs, protein carbonyl, GSH, SOD, catalase) and inflammatory markers (COX, LOX, NO) were scrutinized as well. Oral administration of mefloquine normalised the heart rate with favourable regulation of time and frequency domain HRV parameters. Mefloquine restored the blood glucose, serum insulin, and liver glycogen levels favourably in diabetic rats. Treatment with mefloquine curtailed the antioxidant markers with favourable regulation of inflammatory signals. Mefloquine was also found to be less hepatotoxic in contrast to the standard metformin, providing an integrated advantage as an antidiabetic agent. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png 3 Biotech Springer Journals

Antidiabetic activity of mefloquine via GLP-1 receptor modulation against STZ–NA-induced diabetes in albino wistar rats

Download PDF
10 pages

Loading next page...
 
/lp/springer_journal/antidiabetic-activity-of-mefloquine-via-glp-1-receptor-modulation-JxRPTY3GFM
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer-Verlag GmbH Germany, part of Springer Nature
Subject
Chemistry; Biotechnology; Agriculture; Cancer Research; Bioinformatics; Stem Cells; Biomaterials
ISSN
2190-572X
eISSN
2190-5738
DOI
10.1007/s13205-018-1250-y
Publisher site
See Article on Publisher Site

Abstract

Mefloquine was retrieved as a glucagon -like peptide-1 receptor agonist and, therefore, evaluated for its antidiabetic potential against non-insulin-dependent diabetes mellitus (NIDDM) in experimental animals. NIDDM was induced by single intraperitoneal injection of streptozotocin and nicotinamide (60 + 110 mg/kg) in albino wistar rats. The experimental animals were scrutinised for electrocardiographic (ECG) and heart rate variability (HRV) factors to study the autonomic dysfunction along with blood glucose, serum insulin, and liver glycogen levels for glycemic control. Simultaneously, antioxidant markers (TBARs, protein carbonyl, GSH, SOD, catalase) and inflammatory markers (COX, LOX, NO) were scrutinized as well. Oral administration of mefloquine normalised the heart rate with favourable regulation of time and frequency domain HRV parameters. Mefloquine restored the blood glucose, serum insulin, and liver glycogen levels favourably in diabetic rats. Treatment with mefloquine curtailed the antioxidant markers with favourable regulation of inflammatory signals. Mefloquine was also found to be less hepatotoxic in contrast to the standard metformin, providing an integrated advantage as an antidiabetic agent.

Journal

3 Biotech – Springer Journals

Published: May 4, 2018

References

  • Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia
    Bischof, MG; Bernroider, E
  • Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation
    Bjerre Knudsen, L; Madsen, LW
  • The determination of glycogen in liver and muscle by use of anthrone reagent
    Carroll, NV; Longley, RW
  • Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor
    Dillon, JS; Tanizawa, Y
  • Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1—based therapies
    Elashoff, M; Matveyenko, AV
  • Heart rate changes in diabetes mellitus
    Ewing, D; Campbell, I
  • Long-acting glucagon-like peptide 1 receptor agonists
    Garber, AJ
  • Pentoxifylline decreases glycemia levels and TNF-alpha, iNOS and COX-2 expressions in diabetic rat pancreas
    Garcia, FAO; Pinto, SF
  • Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization
    Giustarini, D; Rossi, R
  • Efficacy of variable dosage of aspirin in combating methotrexate-induced intestinal toxicity
    Gupta, SK; Gautam, S
  • Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
    Hölscher, C
  • ACP journal club: prolonged PR intervals were associated with increased risk for atrial fibrillation, pacemaker implantation, and mortality
    Homoud, MK
  • Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats
    Howarth, F; Jacobson, M
  • Long-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats
    Howarth, F; Jacobson, M
  • cAMP mediators of pulsatile insulin secretion from glucose-stimulated single β-cells
    Idevall-Hagren, O; Barg, S
  • The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise
    Jensen, J; Rustad, PI
  • Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic rats
    Jia, J; Zhang, X
  • Effect of aloe vera (Aloe barbadensis Miller) gel on doxorubicin-induced myocardial oxidative stress and calcium overload in albino rats
    Kaithwas, G; Dubey, K
  • In vitro antioxidant and in vivo antidiabetic, antihyperlipidemic activity of linseed oil against streptozotocin-induced toxicity in albino rats
    Kaithwas, G; Majumdar, DK
  • Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes
    Komers, R; Lindsley, JN
  • PR and OTc interval prolongation on the electrocardiogram after binge drinking in healthy individuals
    Lorsheyd, A; Lange, D
  • Development of a new colorimetric assay for lipoxygenase activity
    Lu, W; Zhao, X
  • Cardiovascular autonomic neuropathy: the clinical significance of its determination
    Maser, RE; Lenhard, JM
  • Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide
    Masiello, P; Broca, C
  • Metformin-induced hepatotoxicity
    Miralles-Linares, F; Puerta-Fernandez, S
  • Electrocardiogram screening for left high R-wave predicts cardiovascular death in a Japanese community-based population: NIPPON DATA90
    Nakamura, K; Okamura, T
  • cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets
    Nakazaki, M; Crane, A
  • Inhibition of cyclooxygenase-2 causes a decrease in coronary flow in diabetic mice. The possible role of PGE2 and dysfunctional vasodilation mediated by prostacyclin receptor
    Przygodzki, T; Talar, M
  • T-wave alternans and heart rate variability: a comparison in patients with myocardial infarction with or without diabetes mellitus
    Ren, L; Fang, X
  • [38] Oxidative damage to proteins: spectrophotometric method for carbonyl assay
    Reznick, AZ; Packer, L
  • Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2
    Riendeau, D; Percival, M
  • Cardiovascular autonomic neuropathy testing in patients with diabetes
    Schumer, MP; Joyner, SA
  • PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis
    Seino, S; Shibasaki, T
  • Effect of obesity on P-wave dispersion and QT dispersion in women
    Seyfeli, E; Duru, M
  • Antihyperglycemic and antioxidant potential of polysaccharide fraction from portulaca oleracea seeds against streptozotocin-induced diabetes in rats
    Sharma, A; Kaithwas, G
  • Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats
    Shirali, S; Zahra Bathaie, S
  • The effect of glucagon-like peptide 1 on cardiovascular risk
    Sivertsen, J; Rosenmeier, J
  • Diabetic cardiovascular autonomic neuropathy
    Vinik, AI; Ziegler, D
  • The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review
    Wulffelé, EM; Kooy, A